Drug Profile
Follitropin biosimilar - Biocad
Latest Information Update: 06 Jul 2015
Price :
$50
*
At a glance
- Originator Biocad
- Class Follicle stimulating hormones; Peptide fragments; Pituitary gonadotropins; Recombinant proteins
- Mechanism of Action Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Female infertility
Most Recent Events
- 06 Jul 2015 Discontinued - Preclinical for Female infertility in Russia (unspecified route) (Biocad pipeline, July 2015)